Research on Burden of Disease for Patients With Myocardial Infarction Combining Dyslipidemia in China

Last updated: January 30, 2019
Sponsor: China Cardiovascular Association
Overall Status: Active - Recruiting

Phase

N/A

Condition

Heart Defect

Congestive Heart Failure

Blood Clots

Treatment

N/A

Clinical Study ID

NCT03691246
GUSU17003
  • All Genders

Study Summary

This study is medical record review and questionnaire survey on the economic burden on Chinese patients with myocardial infarction accompanied by dyslipidemia in a real-world environment.

The primary objective of the study is to investigate the economic burden of disease on patients and the factors influencing it, which may include the mode of treatment for dyslipidemia, drugs for the secondary prevention of myocardial infarction, the outcome of treatment for dyslipidemia, adverse drug reactions and major cardiovascular events.

The secondary objectives of the study include:

  1. patient compliance with medication;

  2. health-related quality of life (HRQoL) in patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients were hospitalized because of acute myocardial infarction in a study hospitalbetween January 1, 2016 and December 31, 2016. If a patient was hospitalized becauseof multiple occurrences of myocardial infarction during this period, his/her initialhospitalization because of myocardial infarction will be considered indexhospitalization. Patients undergo continuous screening in a reverse order based ontime.

  • Patients did not die during "index hospitalization".

  • Patients had Low-density lipoprotein≥1.8 mmol/L shown by the first measurement ofblood lipids or were using lipid-regulating drugs at the first measurement of bloodlipids during "index hospitalization" in 2016.

  • Patients consent to participate in this study and grant informed consent; or thefamily of a patient who died before telephone screening consents to provide relevantinformation and grant informed consent.

Exclusion

Exclusion Criteria:

  • Patients participated in interventional clinical trials after "index hospitalization".

  • Patients had paid <5 visits to the outpatient clinics of a study hospital within oneyear since discharge after "index hospitalization" (if patients who have died withinone year since discharge after "index hospitalization").

  • There is a barrier to communication with a patient or his/her family (if the patienthas died); a patient or his/her family (if the patient has died) cannot correctlyunderstand and answer questions normally.

Study Design

Total Participants: 900
Study Start date:
November 15, 2018
Estimated Completion Date:
June 30, 2019

Study Description

This study is a multicenter retrospective cohort survey study using a cross-sectional design. It is conducted mainly by a medical record review, questionnaire survey and medical examination to collect data.

Connect with a study center

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong 510080
    China

    Active - Recruiting

  • Wuhan Asia Heart Hospital

    Wuhan, Hubei 430022
    China

    Active - Recruiting

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu 210008
    China

    Active - Recruiting

  • Zhongshan Hospital

    Shanghai, Shanghai 200032
    China

    Active - Recruiting

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan 610072
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.